Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
2022-01-04 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-01-03 $0.000001 $0.000001 $0.000001 $0.000001 0
2021-12-31 $0.0011 $0.0011 $0.000001 $0.000001 31 595
2021-12-30 $0.000001 $0.000001 $0.000001 $0.000001 10 000
2021-12-29 $0.000001 $0.000001 $0.000001 $0.000001 25
2021-12-28 $0.000001 $0.000001 $0.000001 $0.000001 0
2021-12-27 $0.000001 $0.000001 $0.000001 $0.000001 50
2021-12-23 $0.000001 $0.000001 $0.000001 $0.000001 894
2021-12-22 $0.0001 $0.0001 $0.0001 $0.0001 0
2021-12-21 $0.0001 $0.0001 $0.0001 $0.0001 625
2021-12-20 $0.0001 $0.0001 $0.0001 $0.0001 17 752
2021-12-17 $0.0002 $0.0002 $0.0002 $0.0002 45 460
2021-12-16 $0.0002 $0.0002 $0.0002 $0.0002 1 000
2021-12-15 $0.0002 $0.0002 $0.0002 $0.0002 2 495
2021-12-14 $0.0001 $0.0002 $0.0001 $0.0002 29 505
2021-12-13 $0.0001 $0.0001 $0.0001 $0.0001 4 136
2021-12-10 $0.0001 $0.0001 $0.0001 $0.0001 3 537
2021-12-09 $0.0001 $0.0001 $0.0001 $0.0001 3 860
2021-12-08 $0.0001 $0.0001 $0.0001 $0.0001 41 187
2021-12-07 $0.0001 $0.0001 $0.0001 $0.0001 15 194
2021-12-06 $0.0001 $0.0001 $0.0001 $0.0001 145
2021-12-03 $0.0001 $0.0001 $0.0001 $0.0001 3 000
2021-12-02 $0.0001 $0.0001 $0.0001 $0.0001 4 914
2021-12-01 $0.0001 $0.0001 $0.0001 $0.0001 78 009
2021-11-30 $0.0001 $0.0002 $0.0001 $0.0002 2 375
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT